UTI Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

UTI Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

1,217 Cr

Lock In Period

N/A

Expense Ratio

2.16

Exit Load

1% if less than 30 days, Nil if greater then or equals to 30 days.

Benchmark

BSE Healthcare Total Return

Summary

UTI Healthcare Fund Growth NAV is ₹320.7674 as of 26 Jun, 2026. UTI Healthcare Fund Growth has delivered 101.33% returns since its launch. The minimum SIP investment amount in UTI Healthcare Fund Growth is ₹500. The AUM of UTI Healthcare Fund Growth is ₹1,217 Cr. The expense ratio of the fund is 2.16%, and its benchmark is BSE Healthcare Total Return. The current exit load of the fund is 1% if less than 30 days, Nil if greater then or equals to 30 days.. In the last 1M months, UTI Healthcare Fund Growth has delivered 4.31% returns.

UTI Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M4.310.834.47
6M12.872.1215.28
1Y15.455.2217.24
3Y26.2716.08108.02

Portfolio Analysis

  • Equity: 94.46%
  • Debt: 5.55%
  • Others
As on: 2026-05-31
View allocation % by

1. SUN PHARMACEUTICALS INDUSTRIES8.87%
2. DIVIS LABORATORIES LTD.4.87%
3. AJANTA PHARMA LTD.4.70%
4. GLAND PHARMA LTD.3.98%
5. LUPIN LTD.3.80%
6. DR REDDYS LABORATORIES LTD.3.11%
7. CAPLIN POINT LABORATORIES LTD3.08%
8. ALKEM LABORATORIES LTD3.07%
9. PROCTOR & GAMBLE HEALTH LTD2.49%
10. COHANCE LIFESCIENCES LIMITED2.48%
11. GLENMARK PHARMACEUTICALS LTD.2.42%
12. IPCA LABORATORIES LTD.2.42%
13. VIYASH SCIENTIFIC LTD2.36%
14. ANTHEM BIOSCIENCES LTD2.33%
15. MARKSANS PHARMA LTD.2.30%
16. SAI LIFE SCIENCES LTD2.19%
17. AUROBINDO PHARMA LTD.1.88%
18. CIPLA LTD.1.73%
19. SUDEEP PHARMA LIMITED1.72%
20. ERIS LIFESCIENCES LTD1.55%
21. PFIZER LIMITED1.35%
22. WINDLAS BIOTEC LTD1.16%
23. ALEMBIC PHARMACEUTICALS1.02%
24. EMCURE PHARMACEUTICALS LTD0.97%
25. AARTI PHARMALABS LTD0.78%
26. JUBILANT PHARMOVA LIMITED0.73%
27. BIOCON LTD.0.70%
28. ORCHID PHARMA LTD.0.66%
29. SYNGENE INTERNATIONAL LTD.0.59%

1. APOLLO HOSPITALS ENTERPRISE LT3.56%
2. FORTIS HEALTHCARE LTD.3.05%
3. MAX HEALTHCARE INSTITUTE LTD2.74%
4. GLOBAL HEALTH LTD.2.25%
5. JUPITER LIFE LINE HOSPITALS LTD1.97%
6. ASTER DM HEALTHCARE LTD1.94%
7. METROPOLIS HEALTHCARE LTD1.77%
8. RAINBOW CHILDRENS MEDICARE LTD1.64%
9. KRISHNA INSTITUTE OF MEDI SCIE1.44%
10. VIJAYA DIAGNOSTIC CENTRE LTD1.42%
11. DR LAL PATHLABS LTD.1.32%

1. LAXMI DENTAL LIMITED1.14%

About Fund UTI Healthcare Fund Growth

UTI Healthcare Fund Growth managed by UTI Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,217 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.16. Under the expert guidance of Kamal Gada ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Kamal Gada

Mr. Kamal Gada is B.com, CA, CS, & CFA. Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.

Peer Comparison

Fund Name1Y3Y
This FundDSP Healthcare Fund Growth12.100882.7084
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth15.304887.2213
This FundMirae Asset Healthcare Fund Growth15.236990.9826
This FundSBI Healthcare Opportunities Fund Growth16.059293.0217
This FundUTI Healthcare Fund Growth15.4472101.3321

UTI Healthcare Fund Growth FAQs

UTI Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of UTI Healthcare Fund Growth is 2.16. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

UTI Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 4.31%
  • 6 Months : 12.87%
  • 1 Year : 15.45%
  • 3 Years : 26.27%
Returns of UTI Healthcare Fund Growth are updated daily based on NAV of ₹ 320.7674 as on Jun 25,2026. Since inception, the return has been 101.33%.

You can invest in UTI Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of UTI Healthcare Fund Growth is ₹1,217 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in UTI Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.